UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives

The oncologist (Dayton, Ohio), 2001-10, Vol.6 (5), p.415-427

2001

Volltextzugriff (PDF)

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours

European Journal of Cancer, 2009-07, Vol.45 (10), p.1764-1772

2009

Volltextzugriff (PDF)

11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer

European journal of cancer (1990), 2014-11, Vol.50, p.199-199

2014

Volltextzugriff (PDF)

4 INVITED C-Met as a target in clinical oncology; rationale and current achievements

European journal of cancer supplements, 2008, Vol.6 (12), p.3-4

Eskens, F.A.L.M

2008

Volltextzugriff (PDF)

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

Radiotherapy and oncology, 2021-02, Vol.155, p.232-236

2021

Volltextzugriff (PDF)

235 HEPATOCELLULAR CARCINOMA AND UNDERLYING LIVER CIRRHOSIS; INFLUENCE ON TREATMENT OR A PROGNOSTIC VALUE?

Journal of hepatology, 2010, Vol.52, p.S99-S99

2010

Volltextzugriff (PDF)

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933

European journal of cancer (1990), 2002-05, Vol.38 (8), p.1090-1099

2002

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy Following Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Feasibility Study

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e30-e30

2021

Volltextzugriff (PDF)

IIIA.4 Side-effects of targeted therapy

Critical reviews in oncology/hematology, 2006-11, Vol.60, p.S6-S6

Eskens, F.A.L.M.

2006

Volltextzugriff (PDF)

Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii158

2018

Volltextzugriff (PDF)

A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii418-viii418

2018

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

European journal of cancer (1990), 2003-05, Vol.39 (7), p.917-926

2003

Volltextzugriff (PDF)

Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives

International journal of nephrology and renovascular disease, 2019-05, Vol.12, p.137-141

2019

Volltextzugriff (PDF)

Safety, pharmacokinetics (PK) and pharmacodynamics (PD) data from a phase I dose-escalation study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600) in combination with utomilumab, a 4-1BB agonistic mAb

Annals of oncology, 2017-09, Vol.28, p.v406-v406

2017

Volltextzugriff (PDF)

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors

Annals of oncology, 2006-08, Vol.17 (8), p.1320-1327

2006

Volltextzugriff (PDF)

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination

European journal of cancer (1990), 2006-03, Vol.42 (4), p.467-472

2006

Volltextzugriff (PDF)

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours

European journal of cancer (1990), 2002-11, Vol.38 (17), p.2272-2278

2002

Volltextzugriff (PDF)

Temozolomide chemotherapy in recurrent oligodendroglioma

Neurology, 2001-07, Vol.57 (2), p.340-342

2001

Volltextzugriff (PDF)

Tivozanib: a new treatment option for renal cell carcinoma

Drugs of Today, 2017-11, Vol.53 (11), p.609-618

2017

Volltextzugriff (PDF)

Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus

Annals of oncology, 2003-08, Vol.14 (8), p.1253-1257

2003

Volltextzugriff (PDF)

Farnesyl transferase inhibitors: current developments and future perspectives

Cancer treatment reviews, 2000-10, Vol.26 (5), p.319-332

2000

Volltextzugriff (PDF)

38 POSTER Phase I and pharmacological study of KRN951, a potent VEGFR tyrosine kinase inhibitor given in a 4 week on, 2 week off schedule in patients with advanced solid tumors

European journal of cancer supplements, 2006-11, Vol.4 (12), p.16-16

2006

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours

11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer

4 INVITED C-Met as a target in clinical oncology; rationale and current achievements

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

235 HEPATOCELLULAR CARCINOMA AND UNDERLYING LIVER CIRRHOSIS; INFLUENCE ON TREATMENT OR A PROGNOSTIC VALUE?

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933

Stereotactic Body Radiation Therapy Following Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Feasibility Study

IIIA.4 Side-effects of targeted therapy

Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib

A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives

Safety, pharmacokinetics (PK) and pharmacodynamics (PD) data from a phase I dose-escalation study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600) in combination with utomilumab, a 4-1BB agonistic mAb

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors

Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours

Temozolomide chemotherapy in recurrent oligodendroglioma

Tivozanib: a new treatment option for renal cell carcinoma

Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus

Farnesyl transferase inhibitors: current developments and future perspectives

38 POSTER Phase I and pharmacological study of KRN951, a potent VEGFR tyrosine kinase inhibitor given in a 4 week on, 2 week off schedule in patients with advanced solid tumors

Suchergebnisse filtern